ca.news.yahoo.com·3 min read·medium
Why Nova Scotia was chosen to test a new Ebola vaccine
C
CBC
✦AI Summary
Moderna has launched a Phase 1 clinical trial for a new Ebola vaccine targeting the Bundibugyo strain in Nova Scotia and Toronto. The sites were selected due to established partnerships and the region's expertise in vaccine research.
A man walks past an Ebola awareness painting on a wall in downtown Monrovia, Liberia, in this file photo. (Ahmed Jallanzo/EPA - image credit) The first human trial of a new Ebola vaccine is underway at two sites in Nova Scotia as well as in Toronto.
healthscience
✦
Get the full story
Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.
Create free accountAlready have an account? Sign in